SANGINITA NSE filing

Sanginita Chemicals Reports Audited Financial Results for FY26; Board Meeting Held

The RealCase readMedium impact Negative

Sanginita Chemicals reported audited financial results for the year ended March 31, 2026, with a loss before tax of ₹972.52 lakhs. Revenue from operations stood at ₹17645.81 lakhs. The company also entered a Share Swap and Share Purchase Agreement, involving a total transaction value of approximately ₹25 crore, subject to approvals.

Why it matters

The financial results show a loss, but the ongoing corporate actions like the share swap agreement indicate potential future strategic moves. The impact is moderate as the financial performance is negative, but the strategic transaction could bring future changes.

The market read

The company reported a significant loss for the quarter and the full financial year, which is a negative indicator.

Sanginita Chemicals Limited announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors convened a meeting on April 25, 2026, commencing at 3:00 p.m. and concluding at 4:00 p.m., to take on record these results. The company operates solely within the "Chemical Business" segment.

Additionally, Sanginita Chemicals declared that its auditors have issued a report with unmodified opinions regarding the financial results for the year ended March 31, 2026. The company also confirmed that there has been no deviation or variation in the utilization of issue proceeds, as per SEBI regulations.

The financial results indicate a loss for the quarter and year ended March 31, 2026. For the quarter, the loss before tax was ₹634.05 lakhs, and for the full year, the loss before tax was ₹972.52 lakhs. Revenue from operations for the quarter was ₹4297.17 lakhs, and for the year, it was ₹17645.81 lakhs.

Furthermore, the company disclosed a Share Swap and Share Purchase Agreement (SSSPA) dated March 20, 2026. This agreement involves the transfer of existing promoter shareholding to B N G Investment LLC and Mr. Anubhav Agarwal. Subject to approvals, the company plans to issue equity shares via share swap to B N G Investment LLC for acquiring shares in Agastya Green Energy Limited (AGEL) and on a preferential basis for cash consideration. The total aggregated amount for these transactions is ₹24,99,99,894 (approximately ₹25 crore). The company has applied to NSE for in-principle approval.

The company also noted that the final financial impact of the New Labour Codes, notified on November 21, 2025, is yet to be assessed as state government rules are still under finalization.

Filing to action

What to do with a filing like this

Sanginita Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sanginita Chemicals Limited. Read the original for the full detail.

View original filing